Abstract:PURPOSE: This study was to investigate the effect of moderate intensity aerobic exercise on diabetic myocardial fibrosis via observing the expression levels of FGF21 and NLRP3 in db/db mice. METHODS: Thirty-two male db/db mice were randomly divided into sedentary groups (group D and group DI) and exercise groups (group DE and group DEI), eight mice in each group. The mice in exercise groups received 12 weeks of treadmill exercise at the intensity of 55% VO2max with the frequency of 50 minutes per times, 5 days per week. The mice in groups DI and DEI received Mcc950 (with dose 10 mg/Kg via i.p.) of three times per week to specifically inhibit the expression of NLRP3 and reduce inflammatory reaction. Mice were weighed, the body compositions were measured, the morphology and fibrosis of the myocardial tissue was observed by HE and Masson staining respectively, the expression levels of FGF21, FGFR1, NLRP3 and ASC were measured by immunofluorescent staining. RESULTS: The body weight of mice in DE(35.46 ± 1.95 g), DI(34.58 ± 2.05 g) and DEI(30.63 ± 2.51 g) groups were significantly lower than that in group D(40.28 ± 1.25 g) (P < 0.01). The volume fraction of myocardial collagen in DE(48.09 ± 1.66%), DI(47.3 ± 2.75%) and DEI(42.34 ± 1.31%) groups was significantly lower than that in D(58.61 ± 2.38%) group (P < 0.05). Compared with group D(59.01 ± 2.13)(69.77 ± 0.49), the protein expression level of FGF21 and FGFR1 of mice in group DE(87.97 ± 3.98)(107.2 ± 2.29) and group DEI (115.5 ± 3.40) (116.5 ± 7.6)increased (P < 0.05). While there was no difference for the expression of FGF21 related protein between group DI (63.89 ± 2.64) (72.77 ± 2.5) with group D. Compared with group D(92.1 ± 1.08)(214.3 ± 1.17), the protein expression level of NLRP3 and ASC of mice in group DE(56.27 ± 0.85)(190.5 ± 4.23) and in group DI (54.16 ± 0.97)(201.9 ± 3.68) decreased (P < 0.05, P < 0.01). Compared with group DI, the expression level of NLRP3 protein of mice in DEI(46.14 ± 0.85) group decreased (P < 0.05). CONCLUSIONS: Moderate intensity aerobic exercise can alleviate myocardial fibrosis in diabetes, by increasing expression of FGF21 and inhibiting the expression of NLRP3 related protein. ACKNOWLEDGEMENTS: This study was supported by the fundamental research funds for the Central Universities of China (2021TD012).

Research on Effect of FGF21 on Reducing Myocardial Fibrosis in Type 1 Diabetic Mice

Reduction of Cardiac Function Induced by FGF21siRNA in Type 1 Diabetic Mice

Mechanisms of the Role of Fibroblast Growth Factor 21 in Attenuating Insulin Resistance

Fibroblast Growth Factor 21 Inhibition Aggravates Cardiac Dysfunction in Diabetic Cardiomyopathy by Improving Lipid Accumulation

Therapeutic Effect of Trichosanthes Fruit Extract on Myocardial Fibrosis in Streptozotocin Induced Diabetic Mice

Moderate Intensity Aerobic Exercise Improves Myocardial Fibrosis in Db/db Mice Byincreasing Fgf21and Inhibiting Nlrp3levels

FGF21 Deletion Exacerbates Diabetic Cardiomyopathy by Aggravating Cardiac Lipid Accumulation

Fibroblast Growth Factor-21 Mediates Hepatic Glucose Metabolism of Type 1 Diabetes Model and Its Mechanism

Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart

Protective effect of fibroblast growth factor 21 on cardiomyocyte hypertrophy induced by high glucose

Fibroblast Growth Factor 21 Deletion Aggravates Diabetes-Induced Pathogenic Changes in the Aorta in Type 1 Diabetic Mice

Protective effect of FGF21 on type 1 diabetes-induced testicular apoptotic cell death probably via both mitochondrial- and endoplasmic reticulum stress-dependent pathways in the mouse model

[Effects of Insulin-Like Growth Factor-1 on the Myocardium in Diabetic Rats].

Improving Hyperglycemic Effect of FGF-21 is Associated with Alleviating Inflammatory State in Diabetes

Inhibition of Mir-21 Alleviated Cardiac Perivascular Fibrosis Via Repressing EndMT in T1DM.

Fibroblast growth factor 21 improves insulin sensitivity by modulating the bile acid-gut microbiota axis in type Ⅱ diabetic mice

Inhibition of Vascular Neointima Hyperplasia by FGF21 Associated with FGFR1/Syk/NLRP3 Inflammasome Pathway in Diabetic Mice

[Therapeutic Effect of Fibroblast Growth Factor 21 on NAFLD in MSG-iR Mice and Its Mechanism].

Fibroblast Growth Factor 21 Attenuates Hepatic Fibrogenesis Through TGF-β/smad2/3 and NF-κB Signaling Pathways.

Fibroblast growth factor 21 inhibited inflammation and fibrosis after myocardial infarction via EGR1

The role of nonmyocardial cells in the development of diabetic cardiomyopathy and the protective effects of FGF21: a current understanding